# Kuwa Free! - Live Free!

> **NCT05044962** · NA · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 700 (estimated)

## Conditions studied

- HIV Infections
- Contraception
- Drug-drug Interaction

## Interventions

- **DRUG:** Cabotegravir/ Rilpivirine
- **DRUG:** Etonogestrel (ETG) implant
- **DRUG:** Intramuscular depo-medroxyprogesterone acetate (IM DMPA)
- **DRUG:** Levonorgestrel
- **DRUG:** NNRTI, PI, or INSTI-containing 1st or 2nd line ART regimens

## Key facts

- **NCT ID:** NCT05044962
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-26
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05044962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05044962, "Kuwa Free! - Live Free!". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05044962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*